Meet our members: Yvan Devaux

News & Events

25 March 2025
AUTHOR: HFPN Admin

Head of the Cardiovascular Research Unit, Luxembourg Institute of Health

What led you to work in the field of heart failure?

In 2005, I joined the cardiovascular research team at the Luxembourg Institute of Health. Heart failure was the major focus area at this time, and remains so to this day. After almost 19 years, the management of heart failure has greatly improved, yet more research is needed to resolve unmet care needs.

 

What does an average day look like for you?

Starting early in the morning, my laboratory team and I discuss ongoing research projects and technical challenges, and we share findings and promising results. The coordination and management of research projects is my main occupation, from funding applications to the publication of results. I also dedicate part of my time to organising networking activities and communicating with stakeholders.

 

In the field of heart failure, what’s working well in Luxembourg, and what could be improved?

We have strong medical management of heart failure, with a heart failure clinic at the main hospital. And it was great to be involved in the development of a National Plan for Cardio-Cerebro-Vascular Diseases, which launched in 2023. Our National Society of Cardiology is working well to raise awareness of heart failure, but this needs to be strengthened further. It is also important for heart failure to become one of the main strategic pillars for research in Luxembourg, since its prevalence is continuously rising.

 

What motivated you to join the Heart Failure Policy Network?

Having been a coordinator of research networks for many years (e.g. Cardiolinc, CardioRNA COST Action, AtheroNET COST Action), I wanted to extend the scope of my policy activities. Joining the HFPN helped me gain additional support for informing decision-makers of the importance of investing in heart failure research.

 

What would you like to see from the Network in the future?

I hope the HFPN will produce further concrete outputs to support the medical research community, widen awareness of the risks of heart failure and secure sustainable funding for research.

 

What changes would you like to see in heart failure on a global level?

Recent research findings highlight the potential of implementing personalised healthcare for heart failure patients. Administering the right treatment at the right time, tailored to the patient, will reduce the adverse effects of certain treatments, enhance quality of life and improve overall outcomes.

 

What has been the most interesting or exciting research finding of the past decade?

The most promising research finding is that we can apply tailored diagnostic and treatment strategies to an individual’s profile. Personalised medicine has seen significant progress in the past decade, and further research and development support the implementation of recent discoveries to bedside.

 

Outside of work, what do you enjoy doing?

Physical activity to maintain my health and reduce my risk of heart failure; gardening to reduce daily stress; and keeping bees to produce pure and organic honey – I take one spoonful of my honey every day for a healthy lifestyle!

 

The Heart Failure Policy Network brings together experts who are united in their passion: to improve outcomes for people living with heart failure.

We share profiles of our members to showcase what led them to work in heart failure, and find out about changes they would like to see in prevention and care.

Tagged:

More from News & Events

New guide for regional decision-makers in Spain aims to supp
New guide for regional decision-makers in Spain aims to supp...
10 April 2025
HFPN collaborated with leading experts in Spain to develop a three-step framework to support the transformation of heart failure service in line with the Spanish National Cardiovas...
Read article
Meet our members: Spyridon Gerovasileiou
Meet our members: Spyridon Gerovasileiou...
11 March 2025
We spoke to HFPN member Spyridon Gerovasileiou, Senior Consultant Cardiologist and Heart Failure Lead, Heart Failure Centre, Enköping Hospital; PhD Candidate in Cardiovascular Sci...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Roche Diagnostics, Bayer and Netherlands Heart Institute. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership.